Singular Genomics Sys Analyst Ratings
Singular Genomics Sys Analyst Ratings
While ratings are subjective and will change, the latest Singular Genomics Sys (OMIC) rating was a maintained with a price target of $3.50 to $3.00. The current price Singular Genomics Sys (OMIC) is trading at is $2.24, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2022 | 33.93% | Goldman Sachs | $3.5 → $3 | Maintains | Neutral |
| 08/17/2022 | 100.89% | UBS | $10 → $4.5 | Downgrades | Buy → Neutral |
| 08/10/2022 | 33.93% | B of A Securities | → $3 | Downgrades | Buy → Underperform |
| 08/10/2022 | 56.25% | Goldman Sachs | → $3.5 | Downgrades | Buy → Neutral |
| 07/14/2022 | 123.21% | Goldman Sachs | $9.5 → $5 | Maintains | Buy |
| 05/11/2022 | 324.11% | Goldman Sachs | $11 → $9.5 | Maintains | Buy |
| 04/13/2022 | 391.07% | Goldman Sachs | $17 → $11 | Maintains | Buy |
| 01/07/2022 | 837.5% | B of A Securities | → $21 | Upgrades | Neutral → Buy |
| 06/21/2021 | 1060.71% | B of A Securities | → $26 | Initiates Coverage On | → Neutral |
| 06/21/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 06/21/2021 | 1239.29% | JP Morgan | → $30 | Initiates Coverage On | → Overweight |
| 06/21/2021 | 1462.5% | Goldman Sachs | → $35 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 8 月 11 日 | 33.93% | 高盛 | 3.5 美元 → 3 美元 | 維護 | 中立 |
| 08/17/2022 | 100.89% | 瑞銀（UBS） | 10 美元 → 4.5 美元 | 降級 | 買入 → 中性 |
| 08/10/2022 | 33.93% | B of A 類證券 | → 3 美元 | 降級 | 買入 → 表現不佳 |
| 08/10/2022 | 56.25% | 高盛 | → 3.5 美元 | 降級 | 買入 → 中性 |
| 07/14/2022 | 123.21% | 高盛 | 9.5 美元 → 5 美元 | 維護 | 買 |
| 05/11/2022 | 324.11% | 高盛 | 11 美元 → 9.5 美元 | 維護 | 買 |
| 2022 年 4 月 13 日 | 391.07% | 高盛 | 17 美元 → 11 美元 | 維護 | 買 |
| 2022 年 7 月 1 日 | 837.5% | B of A 類證券 | → 21 美元 | 升級 | 中性 → 買入 |
| 06/21/2021 | 1060.71% | B of A 類證券 | → 26 美元 | 啓動覆蓋範圍開啓 | → 中立 |
| 06/21/2021 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
| 06/21/2021 | 1239.29% | 摩根大通 | → 30 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 06/21/2021 | 1462.5% | 高盛 | → 35 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Singular Genomics Sys Questions & Answers
奇異基因組學系統問題與解答
The latest price target for Singular Genomics Sys (NASDAQ: OMIC) was reported by Goldman Sachs on November 8, 2022. The analyst firm set a price target for $3.00 expecting OMIC to rise to within 12 months (a possible 33.93% upside). 8 analyst firms have reported ratings in the last year.
高盛於2022年11月8日公佈了奇異基因組系統（納斯達克股票代碼：OMIC）的最新目標股價。該分析公司將目標股價定爲3.00美元，預計OMIC將在12個月內升至12個月內（可能上漲33.93％）。去年有8家分析公司公佈了評級。
The latest analyst rating for Singular Genomics Sys (NASDAQ: OMIC) was provided by Goldman Sachs, and Singular Genomics Sys maintained their neutral rating.
Singular Genomics Sys（納斯達克股票代碼：OMIC）的最新分析師評級由高盛提供，Singular Genomics Sys維持中性評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Singular Genomics Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Singular Genomics Sys was filed on November 8, 2022 so you should expect the next rating to be made available sometime around November 8, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Singular Genomics Sys的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Singular Genomics Sys的最新評級是在2022年11月8日發佈的，因此您應該預計下一個評級將在2023年11月8日左右公佈。
While ratings are subjective and will change, the latest Singular Genomics Sys (OMIC) rating was a maintained with a price target of $3.50 to $3.00. The current price Singular Genomics Sys (OMIC) is trading at is $2.24, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的奇異基因組學系統（OMIC）評級保持不變，目標股價爲3.50美元至3.00美元。Singular Genomics Sys（OMIC）目前的交易價格爲2.24美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。